Who is sponsoring NCT00863928?

NCT00863928 is sponsored by Benaroya Research Institute.

What drugs are being tested in NCT00863928?

Interventions: belladonna 16.2 mg and opium 60 mg suppository.

What is the status of NCT00863928?

NCT00863928 is currently COMPLETED.

Last reviewed 2019-04-11 · How we verify

Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy

NCT00863928 NA COMPLETED Results posted

This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.

Details

Lead sponsor	Benaroya Research Institute
Phase	NA
Status	COMPLETED
Enrolment	135
Start date	2008-10
Completion	2009-07

Conditions

Pain

Interventions

belladonna 16.2 mg and opium 60 mg suppository

Primary outcomes

Pain Assessment by Visual Analog Scale at Rest — 24 hours
The Pain Assessment by Visual Analog Scale (VAS) consists of 100 millimeter (mm) horizontal line with two endpoints 1-100, labeled "no pain" and "worst possible pain. "No pain" is the minimum value and "worst possible pain" is the maximum value. Minimum value or "No Pain" is considered a better outcome.

Countries

United States